{
  "title": "What News Was in My In-Box",
  "link": "https://angrybearblog.com/2022/10/what-news-was-in-my-in-box-9#utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=what-news-was-in-my-in-box-9",
  "comments": "https://angrybearblog.com/2022/10/what-news-was-in-my-in-box-9#comments",
  "dc:creator": "run75441",
  "pubDate": "Wed, 26 Oct 2022 10:00:00 +0000",
  "category": [
    "Climate Change",
    "Education",
    "Healthcare",
    "Hot Topics",
    "Journalism",
    "Law",
    "Politics",
    "US/Global Economics",
    "In-Box",
    "October 26 2022"
  ],
  "guid": "https://angrybearblog.com/?p=96770",
  "description": "<p>Quite a few varying articles in healthcare and other topics this week. Pfizer is hoping to make a killing on it mRNA vaccine, shots are approved for 6 months to five-years of age, Medicare Advantage plans, and Novartis is back again with a cancer drug. A COA has blocked student loan relief, lots of talk [&#8230;]</p>\n<p>The post <a rel=\"nofollow\" href=\"https://angrybearblog.com/2022/10/what-news-was-in-my-in-box-9\">What News Was in My In-Box</a> appeared first on <a rel=\"nofollow\" href=\"https://angrybearblog.com\">Angry Bear</a>.</p>\n",
  "wfw:commentRss": "https://angrybearblog.com/2022/10/what-news-was-in-my-in-box-9/feed",
  "slash:comments": 6
}